Thank you for the response. I read your words as three points that all say.... too soon. Also agreed within the employment agreements they receive warrants and grants.
So that being said then correlate for me what has been done by anyone within the Invivo board, management, and staff within the last six months to cause the valuation to be as high as they currently are? Your point that it is to soon to affect the balance sheet is one of my assertions.If it is too soon to affect the balance sheet does it not stand to reason that intrinsic value then comes into play. Which mathematically means this company is overpriced by three dollars per share.
Also, I understand that talented rare skill sets demand higher than normal compensation with perks; I have no problem with that. What I do not understand is why they as compensated leaders paid for by the investors of the company that expect stock holders to put their money on the table and purchase shares but they cannot do the same. Where does the concept of lead by example come into play? Would it not show the market that they are willing to put there mouths, beliefs, and money on the table? These are the people that know the real truths. By refusing to put their money on the table they scream to the entire world, " This spine thing may work but I am not willing to believe Dr. Langers brillance has merit enough to bet on it but it is worth sucking the shareholders dry."
News 
Market Data 
Discover 
